Ideaya Biosciences logo

Ideaya Biosciences share price today

(IDYA)

Ideaya Biosciences share price is $25.19 & ₹2,135.13 as on 14 Dec 2024, 2.30 'hrs' IST

$25.19

-0.59

(-2.29%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Ideaya Biosciences share price in Dollar and Rupees. Guide to invest in Ideaya Biosciences from India. Also see the sentimental analysis on Indian investors investing in Ideaya Biosciences. Get details on the Indian mutual funds that are investing in Ideaya Biosciences. Get Analyst recommendations and forecasts along with all the Ideaya Biosciences's financials.

Ideaya Biosciences share price movements

  • $24.73
    $25.82

    Day's Volatility :4.22%

  • $24.72
    $47.74

    52 Weeks Volatility :48.22%

Ideaya Biosciences Returns

PeriodIdeaya Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-31.6%
-9.7%
0.0%
6 Months
-32.93%
-3.3%
0.0%
1 Year
-28.17%
4.2%
0.0%
3 Years
14.03%
4.2%
-18.1%

Ideaya Biosciences Key Statistics

in dollars & INR

Previous Close
$25.78
Open
$25.69
Today's High
$25.82
Today's Low
$24.73
Market Capitalization
$2.4B
Today's Volume
$754.4K
52 Week High
$47.735
52 Week Low
$24.715
Revenue TTM
$3.9M
EBITDA
$-222.3M
Earnings Per Share (EPS)
$-2.33
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-21.1%

How to invest in Ideaya Biosciences from India?

It is very easy for Indian residents to invest directly in Ideaya Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ideaya Biosciences stock in both rupees (INR) and dollars (USD). Search for Ideaya Biosciences or IDYA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ideaya Biosciences or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ideaya Biosciences shares which would translate to 0.034 fractional shares of Ideaya Biosciences as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Ideaya Biosciences

50%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Ideaya Biosciences on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 50% more investors are searching Ideaya Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Ideaya Biosciences

  • FMR Inc

    14.62%

  • BlackRock Inc

    7.88%

  • Federated Hermes Inc

    6.03%

  • HHG PLC

    5.97%

  • Vanguard Group Inc

    5.55%

  • T. Rowe Price Associates, Inc.

    4.65%

Analyst Recommendation on Ideaya Biosciences

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Ideaya Biosciences(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Ideaya Biosciences

What analysts predicted

Upside of 121.46%

Current:

$25.19

Target:

$55.79

Insights on Ideaya Biosciences

  • Price Movement

    In the last 3 months, IDYA stock has moved down by -31.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 8.03M → 3.92M (in $), with an average decrease of 51.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -52.77M → -51.82M (in $), with an average increase of 1.8% per quarter
  • IDYA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.5% return, outperforming this stock by 56.2%
  • IDYA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 32.1% return, outperforming this stock by 12.5%
  • Price to Sales

    ForIDYA every $1 of sales, investors are willing to pay $493.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Ideaya Biosciences Technicals Summary

Sell

Neutral

Buy

Ideaya Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ideaya Biosciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ideaya Biosciences Inc
-14.52%
-32.93%
-28.17%
14.03%
254.79%
Regeneron Pharmaceuticals, Inc.
-6.54%
-30.04%
-14.88%
11.15%
94.49%
Biontech Se
16.24%
36.11%
17.79%
-58.06%
243.94%
Alnylam Pharmaceuticals, Inc.
-4.84%
56.03%
32.5%
28.46%
104.33%
Vertex Pharmaceuticals Incorporated
-4.18%
-2.1%
12.92%
119.64%
111.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ideaya Biosciences Inc
NA
NA
NA
-2.39
-0.21
-0.16
NA
13.67
Regeneron Pharmaceuticals, Inc.
19.12
19.12
1.15
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ideaya Biosciences Inc
Buy
$2.4B
254.79%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$84.9B
94.49%
19.12
33.61%
Biontech Se
Buy
$28.9B
243.94%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.8B
104.33%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
111.27%
32.84
-4.51%

Ideaya Biosciences Dividend announcements

  • Ideaya Biosciences Earnings

    Ideaya Biosciences’s price-to-earnings ratio stands at None

    Read More

About Ideaya Biosciences

ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya’s investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ventures (wuxi), novartis institute of biomedical research, and alexandria real estate. the company has assembled a world-class drug discovery team and scientific advisory board (sab) that is represented by a nobel laureate and three members of the national academy of sciences. ideaya is located in south san francisco and la jolla, california.
Organization
Ideaya Biosciences
Employees
124
CEO
Mr. Yujiro S. Hata
Industry
Biotechnology

Management People of Ideaya Biosciences

NameTitle
Mr. Yujiro S. Hata
President, CEO & Director
Mr. Andres Ruiz Briseno CPA
Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations
Dr. Michael A. White Ph.D.
Chief Scientific Officer
Dr. Darrin M. Beaupre M.D., Ph.D.
Chief Medical Officer
Dr. Paul A. Barsanti Ph.D.
Chief Technology Officer
Mr. Douglas B. Snyder
Senior VP & General Counsel
Ms. Francine Zelaya
Vice President & Head of Human Resources
Mr. Mick O'Quigley
Chief of Staff & Clinical Development
Mr. Daniel A. Simon
Chief Business Officer
Mr. Stuart Dorman
Chief Commercial Officer

Important FAQs about investing in Ideaya Biosciences from India :

What is Ideaya Biosciences share price today?

Ideaya Biosciences share price today stands at $25.19, Open: $25.69 ; Previous Close: $25.78 ; High: $25.82 ; Low: $24.73 ; 52 Week High: $47.74 ; 52 Week Low: $24.72. The stock opens at $25.69, after a previous close of $25.78. The stock reached a daily high of $25.82 and a low of $24.73, with a 52-week high of $47.74 and a 52-week low of $24.72.

Can Indians buy Ideaya Biosciences shares?

Yes, Indians can invest in the Ideaya Biosciences (IDYA) from India.

With INDmoney, you can buy Ideaya Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ideaya Biosciences at zero transaction cost.

How can I buy Ideaya Biosciences shares from India?

It is very easy to buy Ideaya Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ideaya Biosciences be purchased?

Yes, you can buy fractional shares of Ideaya Biosciences with INDmoney app.

What are the documents required to start investing in Ideaya Biosciences stocks?

To start investing in Ideaya Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ideaya Biosciences

Today’s highest price of Ideaya Biosciences (IDYA) is $25.82.

Today’s lowest price of Ideaya Biosciences (IDYA) is $24.73.

What is today's market capitalisation of Ideaya Biosciences

Today's market capitalisation of Ideaya Biosciences IDYA is 2.4B

What is the 52 Week High and Low Range of Ideaya Biosciences

  • 52 Week High

    $47.74

  • 52 Week Low

    $24.72

How much percentage Ideaya Biosciences is down from its 52 Week High?

Ideaya Biosciences (IDYA) share price is $25.19. It is down by 47.23% from its 52 Week High price of $47.74.

How much percentage Ideaya Biosciences is up from its 52 Week low?

Ideaya Biosciences (IDYA) share price is $25.19. It is up by 1.92% from its 52 Week Low price of $24.72.

What are the historical returns of Ideaya Biosciences?

  • 1 Month Returns

    -14.52%

  • 3 Months Returns

    -32.93%

  • 1 Year Returns

    -28.17%

  • 5 Years Returns

    254.79%

Who is the Chief Executive Officer (CEO) of Ideaya Biosciences

Mr. Yujiro S. Hata is the current Chief Executive Officer (CEO) of Ideaya Biosciences.